148
Oramed Pharmaceuticals Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
Assets
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
157
FY23:
163
FY24:
143
FY25:
133
(positive)
Change from FY21 to FY25
millions USD
FY21:
29.9
FY22:
4.53
FY23:
58.0
FY24:
12.1
FY25:
97.6
Total assets
Change from FY21 to FY25
millions USD
FY21:
178
FY22:
162
FY23:
221
FY24:
155
FY25:
231
Liabilities & Equity
(negative)
Change from FY21 to FY25
millions USD
FY21:
7.37
FY22:
5.75
FY23:
53.2
FY24:
5.69
FY25:
19.1
(negative)
Change from FY22 to FY25
millions USD
FY21:
–
FY22:
4.74
FY23:
4.44
FY24:
4.25
FY25:
12.0
(positive)
Change from FY21 to FY25
millions USD
FY21:
166
FY22:
152
FY23:
164
FY24:
146
FY25:
200
Total liabilities & equity
Change from FY22 to FY25
millions USD
FY21:
–
FY22:
162
FY23:
221
FY24:
156
FY25:
231
All amounts in millions USD